Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by edroseon May 10, 2021 6:59am
112 Views
Post# 33163369

why didn't they do rights offering several months before tak

why didn't they do rights offering several months before taktakeover    they raised 38 million AFTER they wiped out retail investors they can't say they didn't think of this option before they would have rised over 100 million while retail investors had confidence     
IF THEY WOULD HAVE RAISED MONEY THEY WOULD NOT HAVE MET CRITERIA FOR HARDSHIP AT TSX AND would not have been able to takeover prometic and wipe out retail investors    THIS WILL ALL BE EXPOSED IN COURT  
<< Previous
Bullboard Posts
Next >>